Morgan Stanley initiated coverage of Zealand Pharma (ZLDPF) with an Equal Weight rating and DKK 755 price target The company’s next major ...
In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Ascendis Pharma (ASND – Research Report), with a price target of $175.00. The company’s shares closed ...
This is the second successful treatment in a donkey, demonstrating the potential of Innocan's Liposomal CBD injection for human and veterinary use HERZLIYA, Israel and CALGARY, AB, Feb. 10, 2025 ...
As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.
The pharmaceutical industry is at a pivotal moment. Artificial intelligence (AI) is shifting from improving processes to reshaping disease treatment and care delivery. Early adopters are seeing ...
Rocket Pharmaceuticals (RCKT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising ...
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo The U.S. Food and Drug Administration ...
2025 The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.
IPC Indice de Precios Y Cotizaciones 54,160.11 94.39 0.17% ...
Infinity Pharmaceuticals Inc. 0.00% $90.76 ...
Companies that have grown profits and net profit margins over the past 12 months ...
After hours: February 13 at 4:02:17 PM EST Loading Chart for CRNX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results